Search Within

CTCR Scholars

Formats
  1. Meeting Abstract (877)
  2. Journal Article (577)
  3. Review (73)
  4. Research Letter (39)
  5. Editorial (30)
  6. Correspondence (26)
  7. Miscellaneous (19)
  8. Book Section (11)
  9. Guidelines (7)
  10. Conference Paper (4)
Groups
  1. Department of Medicine (1432)
  2. Hematologic Malignancies, Division of (1089)
  3. MSK Grad Students (1031)
  4. Master of Science in Clinical and Translational Cancer Research (996)
  5. Center for Hematologic Malignancies (990)
  6. Survivorship Research (931)

More Groups

People
  1. Sergio Giralt (557)
  2. Miguel-Angel Perales (413)
  3. Michael Scordo (389)
  4. Gunjan Shah (345)
  5. Sean Devlin (334)
  6. Parastoo Dahi (305)

More People

Years
  1. 2025 (118)
  2. 2024 (255)
  3. 2023 (261)
  4. 2022 (230)
  5. 2021 (166)
  6. 2020 (211)

More Years

Publications
  1. Blood (318)
  2. Biology of Blood and Marrow Transplantation (187)
  3. Journal of Clinical Oncology (144)
  4. Annals of Surgical Oncology (87)
  5. Bone Marrow Transplantation (65)
  6. Transplantation and Cellular Therapy (56)

More Publications

Publishers
  1. American Society of Hematology (373)
  2. Elsevier Inc. (343)
  3. American Society of Clinical Oncology (160)
  4. Nature Publishing Group (139)
  5. Springer (107)
  6. American Association for Cancer Research (67)

More Publishers

Results (1663)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Ovarian cancer mutational processes drive site-specific immune evasion
    Journal Article

    Vázquez-García, I.; Uhlitz, F.; Ceglia, N.; Lim, J. L. P.; Wu, M.; Mohibullah, N.; Niyazov, J.; Ruiz, A. E. B.; Boehm, K. M.; Bojilova, V.; more...
    Nature (2022)

    Fulltext@MSK | Save
  • Eprenetapopt plus azacitidine after allogeneic hematopoietic stem-cell transplantation for TP53 -mutant acute myeloid leukemia and myelodysplastic syndromes
    Journal Article

    Mishra, A.; Tamari, R.; DeZern, A. E.; Byrne, M. T.; Gooptu, M.; Chen, Y. B.; Deeg, H. J.; Sallman, D.; Gallacher, P.; Wennborg, A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Gastric-type adenocarcinoma of the cervix: Clinical outcomes and genomic drivers
    Journal Article

    Ehmann, S.; Sassine, D.; Straubhar, A. M.; Praiss, A. M.; Aghajanian, C.; Alektiar, K. M.; Broach, V.; Cadoo, K. A.; Jewell, E. L.; Boroujeni, A. M.; more...
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Dynamic EASIX scores closely predict nonrelapse mortality after allogeneic hematopoietic cell transplantation
    Journal Article

    Nawas, M. T.; Sanchez-Escamilla, M.; Devlin, S. M.; Maloy, M. A.; Ruiz, J. D.; Sauter, C. S.; Giralt, S. A.; Perales, M. A.; Scordo, M.
    Blood Advances (2022)

    Fulltext@MSK | Save
  • Rates and treatment patterns of gallbladder-related emergency general surgery conditions in the cancer population
    Meeting Abstract

    McIntyre, S.; Seier, K.; Jolissaint, J.; Gonen, M.; Soares, K.; Kingham, T. P.; D'Angelica, M. I.; Drebin, J. A.; Jarnagin, W. R.; Wei, A. C.
    Journal of the American College of Surgeons (2022)

    Fulltext@MSK | Save
  • A phase I/II study of prexasertib in combination with irinotecan in patients with relapsed/refractory desmoplastic small round cell tumor and rhabdomyosarcoma
    Meeting Abstract

    Slotkin, E. K.; Mauguen, A.; Ortiz, M. V.; Dela Cruz, F. S.; O'Donohue, T.; Kinnaman, M. D.; Meyers, P. A.; Wexler, L. H.; Rodriguez, S.; Avutu, V.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A phase 1b study to evaluate safety, tolerability, pharmacokinetics, and efficacy of SER-155 in adults undergoing hematopoietic stem cell transplantation to reduce the risk of infection and graft versus host disease (NCT04995653)
    Meeting Abstract

    Ponce, D. M.; Lombardo, M. J.; Ford, C. B.; Peled, J. U.; Van Den Brink, M. R. M.; Tejura, B.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Zolbetuximab plus gemcitabine and nab-paclitaxel (GN) in first-line treatment of claudin 18.2-positive metastatic pancreatic cancer (mPC): Phase 2, open-label, randomized study
    Meeting Abstract

    Park, W.; O'Reilly, E. M.; Furuse, J.; Li, C. P.; Oh, D. Y.; Garcia-Carbonero, R.; Roth, G.; Lee, H. J.; Kunieda, F.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • TTI-622-01: A phase 1a/1b dose-escalation and expansion trial of TTI-622 in patients with advanced hematologic malignancies, including diffuse large B-cell lymphoma (DLBCL)
    Meeting Abstract

    Patel, K.; Sano, D.; Maris, M.; Lesokhin, A. M.; Von Keudell, G.; Doucette, K.; Ramchandren, R.; Pavlov, D.; Uger, R. A.; Molloy, N.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Immunogenomic characterization of biliary tract cancers: Biomarker enrichment for benefit to immune checkpoint blockade
    Meeting Abstract

    Park, W.; Keane, F.; Bandlamudi, C.; Donoghue, M.; de Lara, P. T.; Harding, J. J.; Khalil, D.; McKinnell, Z.; Sterpi, M.; Cao, W.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save